Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Shares Outstanding (2016 - 2025)

Jaguar Health (JAGX) has disclosed Shares Outstanding for 11 consecutive years, with $121.0 as the latest value for Q3 2025.

  • On a quarterly basis, Shares Outstanding rose 1244.44% to $121.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $121.0, a 1244.44% increase, with the full-year FY2024 number at $9.0, down 92.62% from a year prior.
  • Shares Outstanding was $260.0 for Q3 2025 at Jaguar Health, up from $121.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $2.1 million in Q1 2021 to a low of $9.0 in Q4 2021.
  • A 5-year average of $481396.8 and a median of $260.0 in 2025 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: tumbled 100.0% in 2021, then skyrocketed 2025655.56% in 2024.
  • Jaguar Health's Shares Outstanding stood at $9.0 in 2021, then soared by 16066.67% to $1455.0 in 2022, then tumbled by 91.62% to $122.0 in 2023, then crashed by 92.62% to $9.0 in 2024, then skyrocketed by 1244.44% to $121.0 in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Shares Outstanding are $121.0 (Q3 2025), $9.0 (Q2 2025), and $674047.0 (Q1 2025).